664
Participants
Start Date
October 28, 2021
Primary Completion Date
January 19, 2024
Study Completion Date
January 1, 2026
Placebo
Matching Placebo Comparator
AMX0035
Proprietary formulation of taurursodiol and sodium phenylbutyrate
Columbia University, New York
University of Pennsylvania, Philadelphia
Lewis Katz School of Medicine at Temple University, Philadelphia
Johns Hopkins University School of Medicine Outpatient Center, Baltimore
Virginia Commonwealth University, Henrico
Wake Forest University Health Sciences, Winston-Salem
University of North Carolina at Chapel Hill, Chapel Hill
Emory University, Atlanta
Augusta University Neuroscience Center, Augusta
University of Florida, Gainesville
University of South Florida, Tampa
The Ohio State University, Columbus
Hennepin Healthcare Research Institute, Minneapolis
Northwestern University, Chicago
Washington University School of Medicine, St Louis
Somnos Clinical Research, Lincoln
Texas Neurology, Dallas
Austin Neuromuscular Center, Austin
University of Colorado, Aurora
Barrow Neurological Institute, Phoenix
University of Southern California, Los Angeles
University of California Irvine, Orange
California Pacific Medical Center Research Institute, San Francisco
Swedish Neuroscience Institute, Seattle
University of Washington, Seattle
Healey & AMG Center for ALS Research at Massachusetts General Hospital, Boston
University of Massachusetts, Worcester
Rutgers University, New Brunswick
University Hospitals Leuven, Leuven
Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer Cellule Mutualisée de Recherche Clinique (CMRC), Bron
Hopital Gabriel Montpied Service de Neurologie, Clermont-Ferrand
CHRU de Lille - Hôpital Roger Salengro, Lille
CHU de Limoges - Hôpital Dupuytren, Limoges
Hôpitaux Universitaires de Marseille Timone, Marseille
CHU de Montpellier, Montpellier
CHU Nice, Nice
Hôpital de la Salpêtrière, Paris
Le Centre Hospitalier Régional Universitaire de Tours, Tours
Charité - Universitätsmedizin Berlin, Berlin
Uniklinikum Dresden, Dresden
Hannover Medical School, Hanover
Jena University Hospital, Jena
Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim
University Medical Center Rostock, Rostock
Ulm University Medical Centre, Ulm
Trinity College Dublin/Beaumont Hospital, Dublin
Università degli Studi di Bari Aldo Moro, Bari
Centro Clinico NEMO, Milan
University of Milan Medical School, Milan
Azienda Ospedaliero Universitaria Di Modena, Modena
Università degli Studi della Campania Luigi Vanvitelli, Napoli
University of Padua, Padua
University of Torino, Turin
University Medical Center Utrecht, Utrecht
Centrum Medyczne Linden, Krakow
City Clinic Warsaw, Warsaw
Centro Hospitalar Universitário Lisboa-Norte, Lisbon
Hospital del Mar, Barcelona
Hospital Universitari de Bellvitge-IDIBELL, Barcelona
Hospital San Rafael, Madrid
Biodonostia Health Research Institute; Hospital Universitario Donostia, San Sebastián
Hospital Universitario y Politécnico La Fe, Valencia
Karolinska Institutet, Stockholm
Umeå University Hospital, Umeå
King's College London, London
UCL Queen Square Institute of Neurology, London
University of Plymouth, Plymouth
Salford Royal Hospital Barnes, Salford
Sheffield Institute for Translational Neuroscience (SITraN), Sheffield
Lead Sponsor
Amylyx Pharmaceuticals Inc.
INDUSTRY